← All Icu Medical Inc/de filings

Icu Medical Inc/de DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
ICUI
Icu Medical Inc/de
DEF: ICU Medical Faces Regulatory Headwinds Amidst Mixed 2025 Results
ICU Medical's 2026 proxy statement reveals mixed 2025 financial performance, significant regulatory challenges, and proposed corporate governance enhancements.
NASDAQ
ICUI
Icu Medical Inc/de
DEFA14A: ICU Medical, Inc. Files Proxy Statement with SEC
ICU Medical, Inc. has filed a proxy statement with the Securities and Exchange Commission (SEC) in compliance with Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
ICUI
Icu Medical Inc/de
DEF: ICU Medical Seeks Stockholder Approval for Amended Stock Incentive Plan
ICU Medical is asking stockholders to approve an amendment to its stock incentive plan to increase the number of shares available for issuance.
NASDAQ
ICUI
Icu Medical Inc/de
DEFA14A: ICU Medical, Inc. Files Definitive Proxy Statement
ICU Medical, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
ICUI
Icu Medical Inc/de
DEF 14A: ICU Medical, Inc. Announces Details for 2024 Annual Stockholders Meeting
ICU Medical, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on May 15, 2024, to vote on director elections, auditor ratification, executive compensation, and other business.